Stay updated on Dupilumab in AFRS Clinical Trial

Sign up to get notified when there's something new on the Dupilumab in AFRS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dupilumab in AFRS Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A sitewide NIH banner announces updates and FAQs about using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-25T16:12:12.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The clinical trial details have been replaced by a 403 Forbidden message, leaving the study record unavailable on the page.
    Difference
    19%
    Check dated 2026-10-18T22:13:09.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the dupilumab study in allergic fungal rhinosinusitis is displayed, including its eligibility criteria, study design, outcome measures, locations, and supporting documents.
    Difference
    82%
    Check dated 2026-10-11T22:01:47.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study details and navigation with an access-denied screen. This indicates a server-side access issue or restriction that prevents users from viewing the trial record.
    Difference
    19%
    Check dated 2026-09-20T20:47:51.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    No changes were recorded for the page, so the content remains as published.
    Difference
    0.0%
    Check dated 2026-09-13T21:59:14.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Study alias updated from LIBERTY-AFRS-AI to AFRS (AIMS). The 2026 entries reflect a new listing and rebranding of the trial.
    Difference
    0.2%
    Check dated 2026-09-06T22:33:34.000Z thumbnail image

Stay in the know with updates to Dupilumab in AFRS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dupilumab in AFRS Clinical Trial page.